Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1005 | 1122 | 1092 | 1086 | 1395 | 1419 |
Fund Return | 0.52% | 12.25% | 9.23% | 2.78% | 6.89% | 3.56% |
Place in category | 59 | 465 | 128 | 325 | 174 | 333 |
% in Category | 8 | 67 | 22 | 55 | 28 | 80 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TIAA-CREF Equity Index Instl | 15.35B | 5.17 | 6.33 | 11.78 | ||
TIAA-CREF International Eq Idx Inst | 13.18B | 2.47 | 2.79 | 4.42 | ||
TIAA-CREF Large-Cap Gr Idx Instl | 12.36B | 6.66 | 8.42 | 15.41 | ||
TIAA-CREF Large-Cap Value Idx Inst | 8.49B | 4.30 | 5.14 | 8.39 | ||
TIAA-CREF S&P 500 Index Instl | 6.87B | 6.01 | 8.01 | 12.35 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 191.19B | 1.91 | 0.13 | 4.01 | ||
Vanguard Total Intl Stock Index Adm | 73.1B | 1.95 | 0.19 | 4.07 | ||
Fidelity International Index Inst | 48.57B | 2.55 | 2.86 | 4.45 | ||
Fidelity Series Global ex US Index | 44.6B | 2.31 | 0.29 | 3.89 | ||
Vanguard Total Intl Stock Index I | 39.57B | 1.98 | 0.22 | 4.10 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.41 | 920.4 | -0.74% | |
AstraZeneca | GB0009895292 | 3.58 | 12,230.0 | +0.33% | |
Shell | GB00BP6MXD84 | 3.00 | 33.49 | +0.87% | |
Sony | JP3435000009 | 2.84 | 13,085.0 | +1.47% | |
Toyota Motor | JP3633400001 | 2.82 | 3,341.0 | -1.76% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review